PGC1A regulates the IRS1:IRS2 ratio during fasting to influence hepatic metabolism downstream of insulin
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Significance: The liver plays crucial roles in the control of glucose homeostasis during the fast-feeding cycle. It responds to insulin and glucagon to either store or provide glucose to other organs. Insulin resistance is a hallmark of metabolic diseases such as type 2 diabetes and nonalcoholic fatty liver disease. Associations have been made between low hepatic levels of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1A) and hepatic insulin resistance, but underlying mechanisms are elusive. We show that PGC1A controls the hepatic ratio of Insulin Receptor Substrates 1 (IRS1) and IRS2 expression, crucial for defining the precise insulin signal in hepatocytes to respond to fasting and feeding. Importantly, PGC1A is key for insulin-mediated suppression of hepatic glucose production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Studies suggest that IRS1 and IRS2 have distinct roles in regulating hepatic lipid metabolism [20,30,97].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Watterson, K. R., Bestow, D., Gallagher, J., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2013) · Neurosignals · doi:10.1159/000334144 · Cited by 3,389
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028 · cited 1×
“In metabolic disorders such as type 2 diabetes and nonalcoholic fatty liver disease (NAFLD), the liver becomes resistant to the actions of insulin, even in a hyperinsulinemic context (3).”
BackgroundControl of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821 · cited 3×
“Moreover, PGC1A knockdown decreased basal and glucagon-induced G6pc and Pepck mRNA, as previously described (5), as well as Hsl, another PGC1A target (20) not regulated by glucagon (SI Appendix, Fig.”
BackgroundTranscriptional paradigms in mammalian mitochondrial biogenesis and function
Scarpulla, R. C. (2008) · Physiological Reviews · doi:10.1152/physrev.00025.2007 · Cited by 1,666 · cited 1×
“Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1A) is a transcriptional coactivator within a family that includes two other members, peroxisome proliferatoractivated receptor gamma coactivator 1-beta (PGC1B) and peroxisome proliferator-activated receptor gamma coactivatorrelated protein 1 (PP…”
BackgroundmTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex
Cunningham, J. T., Rodgers, J. T., Arlow, D. H., Vazquez, F., Mootha, V. K., & Puigserver, P. (2007) · Nature · doi:10.1038/nature06322 · Cited by 1,488
CREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440 · cited 2×
“To determine whether TCF4 or CREB were necessary for the glucagon/PGC1A/IRS2 axis, we assessed the ability of glucagon and PGC1A to induce IRS2 in the presence of dominantnegative TCF4 (31) or CREB (21).”
BackgroundKoliaki, C., Szendroedi, J., Kaul, K., Jelenik, T., Nowotny, P., Jankowiak, F., Herder, C., Carstensen, M., Krausch, M., Knoefel, W. T., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.004 · Cited by 1,032
Leone, T. C., Lehman, J. J., Finck, B. N., Schaeffer, P. J., Wende, A. R., Boudina, S., Courtois, M., Wozniak, D. F., Sambandam, N., Bernal-Mizrachi, C., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030101 · Cited by 951
Biochemical and cellular properties of insulin receptor signalling
Haeusler, R. A., McGraw, T. E., & Accili, D. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.89 · Cited by 739 · cited 2×
“Since various proteins can directly or indirectly regulate phosphorylation of AKT in response to insulin (2), we hypothesized that, as a transcriptional coactivator, PGC1A might differentially control expression of one or many of these intermediates.”
BackgroundLKB1 and AMP-activated protein kinase control of mTOR signalling and growth
Shaw, R. J. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01972.x · Cited by 644 · cited 1×
“Further studies are warranted to unravel mechanistic connections between PGC1A and mTOR, which could also be complicated by the effects of PGC1A on metabolites sensed by AMPK and mTOR (36).”
Background
Cited by
Items 101–124 of 124
Nacre extract improves insulin resistance and cognitive functions in diabetic mice
Heng, Z., Yotsuya, Y., Omachi, T., & Hasegawa, Y. (2025) · Asian Pacific Journal of Tropical Biomedicine · doi:10.4103/apjtb.apjtb_458_25 · Cited by 2
Machrina, Y., Pane, Y. S., & Lindarto, D. (2020) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2020.4550 · Cited by 4
“PGC-1α level determines the relative ratio of IRS1 and IRS2 in hepatocytes insulin resistance in the liver disrupt the glycogenesis process and increase gluconeogenesis as compensation mechanism of cell requirement for glucose [8], [9], [10], [11].”
BackgroundVidović, V., Maksimović, N., Vidović, S., Damnjanović, T., Milovač, I., & Novaković, I. V. (2022) · Genetika · doi:10.2298/gensr2203375v · Cited by 2
White, M. F. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch9 · Cited by 3
Insulin Resistance Mediates the Association Between Vitamin D and Non-Alcoholic Fatty Liver Disease
Zou, C., Liu, X., He, M., Sun, Y., Sang, Y., Peng, G., Ma, Y., Geng, H., & Liang, J. (2024) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_221_23 · Cited by 1
Sun, Q. L., Xie, L., An, H., Chen, W., Yang, Q., Wang, P., Tang, Y., & Peng, C. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1585030 · Cited by 1
Gong, Y., Zeng, Q., Geng, X., Zhang, J., Kang, X., Tian, Y., & Jiang, R. (2026) · Poultry Science · doi:10.1016/j.psj.2026.106775 · Cited by 1
Effects of different sugar-lipid ratio diets on the occurrence of type 2 diabetes mellitus
Sun, W., Jiang, L., Tang, S., An, X., Ji, H., & Lian, F. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1768263 · Cited by 1
Búci, M., Mészáros, G., Kaňuch, P., & Klinga, P. (2026) · Biological Conservation · doi:10.1016/j.biocon.2026.111904 · Cited by 1
Baek, M., Yang, Y.-M., Kwon, E.-Y., & Choi, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146530 · Cited by 1
The effects of intermittent fasting on liver physiology and metabolism in micePreprint
Ma, J., Cheng, Y., Su, Q., Ai, W., Gong, L., Wang, Y., Li, L., Ma, Z., Pan, Q., Qiao, Z., et al. (2020) · doi:10.21203/rs.2.20239/v1 · Cited by 1
ГЕНЕТИКА ЦУКРОВОГО ДІАБЕТУ 2 ТИПУ ТА ЙОГО ПОЄДНАННЯ З ОЖИРІННЯМ І ХРОНІЧНИМ ПАНКРЕАТИТОМ
Гевко, У. П., & Марущак, М. І. (2021) · Medical and Clinical Chemistry · doi:10.11603/mcch.2410-681x.2020.i4.11748
Liboz, A. (2022) · theses.fr (ABES) · doi:10.70675/9abd3277zd4c4z48f5za637z73aeb8a7a807 · Cited by 1
Абатуров, А. Е., Нікуліна, А. О., & Русакова, О. О. (2024) · CHILD`S HEALTH · doi:10.22141/2224-0551.19.4.2024.1710
Rat Model to Investigate the Effect of Oleuropein on Cardiac Tissue in D-Galactose-Induced Aging
Ranjbar, E., Khorsandi, L. S., & Goudarzi, M. (2025) · Jundishapur Journal of Natural Pharmaceutical Products · doi:10.5812/jjnpp-157831
“Therefore, it has become an attractive target for the development of therapeutic interventions (49-51).”
PGC1α inhibits SiO2-induced fibrosis by regulating the mitochondrial respiratory chain
Liu, S., Zhang, Y., Wang, H., He, H., & Fang, Y. (2025) · Food and Chemical Toxicology · doi:10.1016/j.fct.2025.115615
Güneş, A., Jeromson, S., Schmitt, C., Schoumacher, M., Eng, J., Besse‐Patin, A., Léveillé, M., Monteillet, L., Jouvet, N., Baldwin, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.09.674670
Self-citationGao, X., Zhu, Z., Bao, Y., Li, Y., Zhu, W., He, X., Ge, X., Huang, W., Wang, H., Wei, W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25963184
Cai, B., Qu, J., Yao, D., Huang, T., Huang, X., Song, H., Li, S., Wang, D., Xu, Y., & Wang, Y. (2026) · Environment International · doi:10.1016/j.envint.2026.110333
Olufunmilayo, I. G., Nafisat, A., Shittu, S.-T. T., & Alli, S. (2026) · Advances in Applied Physiology · doi:10.11648/j.aap.20261101.12
Common Mechanisms of Insulin Signaling, Action, and Resistance
White, M. F. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-11985-9.00007-x
The Role of PGC-1α in Breast Cancer Liver Metastasis
Rahimi, E. (2026) · uO Research (University of Ottawa) · doi:10.20381/ruor-32219
Lipolysis-driven communication between adipose tissue and liver: a key axis in metabolic regulation
Zhang, S., Cedillo, L., & Villanueva, C. J. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101150
Metadata
- Authors
- Besse-Patin, A., Jeromson, S., Levesque-Damphousse, P., Secco, B., Laplante, M., & Estall, J. L.
- Affiliations
- Institut de Recherches Cliniques de Montréal (IRCM), Montreal, QC, Canada H2W 1R7;
- Montreal Clinical Research Institute (CA)
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Corresponding author
- Estall, Jennifer L.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2019-02-15
- Volume
- 116
- Issue
- 10
- Pages
- 4285-4290
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC6410797
- OpenAlex
- W2913974217
- Cited by
- 124
- References
- 46
- Citations by year
- 2026: 9 · 2025: 20 · 2024: 20 · 2023: 17 · 2022: 12 · 2021: 21 · 2020: 22 · 2019: 3
- FWCI
- 4.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Gouvernement du Canada | Canadian Institutes of Health Research (SVB-145591)
- Fonds de Recherche du Québec - Santé (35208)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- PGC-1α, IRS-1, insulin receptor substrate 2, insulin signaling, hepatic gluconeogenesis, fasting, glucagon signaling, CREB, Akt, glucose homeostasis, insulin resistance, hepatocytes, non-alcoholic fatty liver disease, type 2 diabetes, cyclic AMP
- MeSH terms
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Animals, Diabetes Mellitus, Type 2, Fasting, Female, Gene Expression Regulation, Glucagon, Gluconeogenesis, Glucose, Homeostasis, Humans, Insulin, Insulin Resistance, Liver, Liver Diseases, Male, Signal Transduction, Cyclic AMP Response Element-Binding Protein, Hepatocytes, Models, Animal, Proto-Oncogene Proteins c-akt, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.